Combination Therapy for Crohn's Disease: When Two Treatments Are Better Than One

Published: Dec 17, 2023

In the battle against Crohn's disease, sometimes one treatment isn't enough. That's where combination therapy comes in. This approach pairs different medications to pack a more powerful punch against inflammation and symptoms.

What is Combination Therapy?

Combination therapy for Crohn's disease typically involves using a biologic drug along with an immunomodulator. Biologics, like infliximab or adalimumab, target specific parts of the immune system to reduce inflammation. Immunomodulators, such as azathioprine or methotrexate, work more broadly to suppress the immune response. Together, they can be more effective than either medication alone.

Benefits of the Tag-Team Approach

Research has shown that combination therapy can be more effective at inducing and maintaining remission in Crohn's disease compared to single-drug treatments. It may lead to faster symptom relief and better healing of the intestinal lining. Additionally, using an immunomodulator alongside a biologic can help prevent the body from developing antibodies against the biologic, allowing it to work better for longer.

Crohn's disease is a chronic inflammatory bowel disease that affects the lining of the digestive tract. Combination therapy for Crohn's involves using a biologic drug with an immunomodulator to reduce inflammation and manage symptoms more effectively.

Potential Risks and Side Effects

While combination therapy can be very effective, it does come with some additional risks. Using two immunosuppressive medications can increase the chance of infections. There's also a small increased risk of certain cancers, particularly lymphoma, especially in younger male patients. However, for many patients, the benefits of better disease control outweigh these risks.

Frequently Asked Questions

It varies, but often for at least a year.

Never stop without consulting your doctor first.

Yes, your doctor can discuss other options.

Often yes, but check with your provider.

Key Takeaways

Combination therapy offers a powerful tool in managing Crohn's disease, but it's not one-size-fits-all.

Wondering if combination therapy might be right for your Crohn's disease? Discuss your treatment options with Doctronic today.

Related Articles

References

Colombel JF, et al. Infliximab, azathioprine, or combination therapy for Crohn's disease. N Engl J Med. 2010;362(15):1383-1395.

Lichtenstein GR, et al. ACG Clinical Guideline: Management of Crohn's Disease in Adults. Am J Gastroenterol. 2018;113(4):481-517.

Always discuss health information with your healthcare provider.